Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline in Relapsed NHL
NCT02086591Phase 2Terminated
- Sponsor
- University of Rochester
- Start
- Mar 2014
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of doxycycline in non-Hodgkin lymphoma (NHL), chronic lymphocytic leukemia (CLL), sponsored by University of Rochester. Started Mar 2014; status: terminated.
02
Drugs
doxycycline
03
Conditions
non-Hodgkin lymphoma (NHL)chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT02086591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02086591.